• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, April 3 Avesthagen Ltd said it has tied up with Dubai Biotechnology and Research Park to market and launch new biotechnology products.

Under a framework agreement, the two will integrate technologies based on traditional Indian medicine and genomic research into predictive, preventive and personalised healthcare products, a release here said.

Avesthagen’s founder and CMD, Dr Villoo Morawala-Patell, signed the agreement with Dr Abdulqader Alkhayat, Executive Director of DuBiotech.

The partners will first launch and commercialise BioPercept, an eco-friendly and biodegradable plastic, in the Gulf Cooperation Council region. A conversion plant to process it is to follow within the next two years.

They will explore future opportunities in environment adjusted crops, agri-biotech, bio-actives for the food and beverage industry, a genome project, herb-based projects, among others, the release said.

More Stories on : Alliances & Joint Ventures | New Products & Services | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Ranbaxy launches new drug for bone disease

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line